pre-seed
Stage
1
Investors
About
Develops a platform for industrial in vivo production of clinical-grade messenger RNA (mRNA) for human and animal health, targeting vaccines and therapeutic applications including infectiology, oncology and rare diseases.
Explore BYoRNA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.